Weiyi Peng to Immunotherapy
This is a "connection" page, showing publications Weiyi Peng has written about Immunotherapy.
Connection Strength
0.582
-
Integrating genome-wide CRISPR immune screen with multi-omic clinical data reveals distinct classes of tumor intrinsic immune regulators. J Immunother Cancer. 2021 02; 9(2).
Score: 0.174
-
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity. Cancer Immunol Immunother. 2021 Apr; 70(4):1101-1113.
Score: 0.171
-
Development of a RIPK1 degrader to enhance antitumor immunity. Nat Commun. 2024 Dec 16; 15(1):10683.
Score: 0.057
-
Clinically translatable cytokine delivery platform for eradication of intraperitoneal tumors. Sci Adv. 2022 Mar 04; 8(9):eabm1032.
Score: 0.047
-
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy. Nat Commun. 2021 Sep 23; 12(1):5606.
Score: 0.046
-
Development of Immunotherapy Combination Strategies in Cancer. Cancer Discov. 2021 Jun; 11(6):1368-1397.
Score: 0.044
-
The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell-Mediated Immunotherapies. Mol Cancer Ther. 2021 Mar; 20(3):500-511.
Score: 0.043